Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

91
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
91
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices01:28

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

131
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
131
Modified-Release Drug Delivery Systems: Rate-Programmed I01:22

Modified-Release Drug Delivery Systems: Rate-Programmed I

106
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
106
Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

124
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
124
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

130
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
130

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Commentary: C6-7 Corpectomy for Clipping of Ruptured Anterior Radiculomedullary Artery Aneurysm.

Operative neurosurgery (Hagerstown, Md.)·2026
Same author

High-fidelity three-dimensional reconstruction of musculoskeletal tissues via diffusion based ultrasonic computed tomography.

Medical image analysis·2026
Same author

Therapeutic targets for diabetic nephropathy identified by druggable genome mendelian randomization: the role of the gut microbiota-metabolite axis.

Frontiers in endocrinology·2026
Same author

Identification of novel covalent ligands that disrupt Acetyl-Lysine binding to the SETDB1 tudor domain.

Biochemical and biophysical research communications·2026
Same author

Region-Adaptive Null Subtraction Imaging Using Generalized Coherence Factor for Coherent Plane Wave Compounding.

Ultrasonic imaging·2026
Same author

Telerehabilitation of chronic low back pain: protocol of a systematic review and network meta-analysis.

Systematic reviews·2026

Related Experiment Video

Updated: Apr 7, 2026

Microinjectrode System for Combined Drug Infusion and Electrophysiology
08:30

Microinjectrode System for Combined Drug Infusion and Electrophysiology

Published on: November 13, 2019

7.4K

Polypyrrole-Based Implantable Electroactive Pump for Controlled Drug Microinjection.

Bingxi Yan, Boyi Li, Forest Kunecke

  • 1‡Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, North Carolina 27695, United States.

ACS Applied Materials & Interfaces
|July 3, 2015
PubMed
Summary
This summary is machine-generated.

Researchers developed a novel electroactive pump for controlled insulin microinjection, offering a promising solution for diabetic patients. This biocompatible polypyrrole device ensures consistent insulin delivery, enhancing diabetes management.

Keywords:
controlled drug deliverydiabeteselectroactuatorimplantablepolypyrrole

More Related Videos

Simultaneous Electrophysiological Recording and Micro-injections of Inhibitory Agents in the Rodent Brain
07:52

Simultaneous Electrophysiological Recording and Micro-injections of Inhibitory Agents in the Rodent Brain

Published on: July 7, 2015

8.7K
Osmotic Pump-based Drug-delivery for In Vivo Remyelination Research on the Central Nervous System
06:07

Osmotic Pump-based Drug-delivery for In Vivo Remyelination Research on the Central Nervous System

Published on: December 17, 2021

6.2K

Related Experiment Videos

Last Updated: Apr 7, 2026

Microinjectrode System for Combined Drug Infusion and Electrophysiology
08:30

Microinjectrode System for Combined Drug Infusion and Electrophysiology

Published on: November 13, 2019

7.4K
Simultaneous Electrophysiological Recording and Micro-injections of Inhibitory Agents in the Rodent Brain
07:52

Simultaneous Electrophysiological Recording and Micro-injections of Inhibitory Agents in the Rodent Brain

Published on: July 7, 2015

8.7K
Osmotic Pump-based Drug-delivery for In Vivo Remyelination Research on the Central Nervous System
06:07

Osmotic Pump-based Drug-delivery for In Vivo Remyelination Research on the Central Nervous System

Published on: December 17, 2021

6.2K

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Electrochemistry

Background:

  • Diabetes management requires precise, long-lasting insulin delivery systems.
  • Existing implantable insulin pumps face challenges in biocompatibility and consistent performance.
  • Electroactive polymers offer potential for advanced actuator-driven medical devices.

Discussion:

  • A novel polypyrrole composite film, doped with a PCL-PTHF-PCL macromolecule, was synthesized for an electroactive pump.
  • Phosphate-buffered saline as an electrolyte significantly enhanced electroactivity and reproducibility compared to chloride-doped polypyrrole.
  • The developed pump actuator demonstrated consistent performance over multiple cycles, crucial for reliable drug delivery.

Key Insights:

  • The PCL-PTHF-PCL doped polypyrrole composite exhibits superior electroactivity and reproducibility for pump applications.
  • The implantable pump achieved a consistent output of 10.5 μL/s at 0.35 mA/cm2 over 20 cycles.
  • This biocompatible electroactive pump represents a significant advancement for controlled insulin microinjection.

Outlook:

  • Further development could lead to implantable insulin pumps with improved longevity and precision.
  • This technology has the potential to significantly enhance the quality of life for individuals with diabetes.
  • Future research may explore other macromolecular dopants and electrolyte systems to optimize pump performance.